搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
ALS News Today
20 小时
Highly targeted approach supports ALS gene therapy development
Researchers have developed a type of gene therapy that can rescue the function of the TDP-43 protein in diseased nerve cells ...
ALS News Today
6 小时
Good memories sustain us when life with ALS is hard
The past is always present, we're told, and that's a comfort for columnist Kristin Neva when she can focus on good memories from before ALS.
ALS News Today
1 天
Neuvivo requests FDA approval of ALS treatment NP001
Neuvivo has filed an application with the U.S. Food and Drug Administration (FDA) requesting the approval of its ...
ALS News Today
2 天
FGF4 shows benefits in ALS but fails to protect motor neurons
In an ALS study, growth factor FGF4 reduced the activity of star-shaped cells called astrocytes but did not stop motor ...
ALS News Today
3 天
Differences in tears can distinguish bulbar-onset ALS vs. spinal-onset
Differences in human tears in ALS can distinguish bulbar-onset disease from spinal-onset ALS, making this a possible ...
ALS News Today
7 天
Target ALS, Modality.AI partner to study AI in ALS
Modality.AI and Target ALS are partnering on a clinical study of AI as a way to assess changes in speech and motor function ...
ALS News Today
2 天
6 simple habits that help me with living with ALS
Living with ALS is easier with six tried-and-tested everyday habits, columnist Dagmar Munn has found. Among them: dressing well.
ALS News Today
6 天
Immune proteins activation at ALS diagnosis linked to progression
Changes in the production of several immune proteins at the time of an ALS diagnosis were linked to disease progression in ...
ALS News Today
13 天
Mabylon gets funding to advance human-derived antibodies for ALS
Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...
ALS News Today
8 天
PrimeC, potential ALS treatment, given US patent for its formulation
The new patent covers Neurosense's formulation of PrimeC, a fixed-dose combo of an approved antibiotic and anti-inflammatory.
ALS News Today
9 天
Phase 1 trial of prosetin to create digital twins of ALS patients
ProJenX teamed with Unlearn to create digital twins of ALS patients as a placebo group in open-label extension of Phase 1 ...
ALS News Today
13 天
A new ALS app called Roon shares wisdom from experts and patients
Columnist Juliet Taylor chats with Roon CEO and co-founder Vikram Bhaskaran about this new ALS app designed for patients and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈